SAMSUNG PHARM. Co., LTD. (KRX:001360)

Market Cap	140.52B
Revenue (ttm)	44.29B
Net Income (ttm)	12.71B
Shares Out	94.12M
EPS (ttm)	n/a
PE Ratio	11.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	351,723
Average Volume	279,941
Open	1,531.00
Previous Close	1,523.00
Day's Range	1,505.00 - 1,546.00
52-Week Range	1,388.00 - 1,990.00
Beta	1.29
RSI	25.41
Earnings Date	n/a

About SAMSUNG PHARM. Co., LTD.

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 240
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001360

Financial Performance

In 2024, SAMSUNG PHARM. Co., LTD.'s revenue was 44.29 billion, a decrease of -14.75% compared to the previous year's 51.96 billion. Earnings were 12.71 billion, a decrease of -48.77%.